Switch to:
Also traded in: Austria, Germany, Italy, Mexico, Switzerland, UK, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.08
FMS's Cash-to-Debt is ranked lower than
78% of the 266 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. FMS: 0.08 )
Ranked among companies with meaningful Cash-to-Debt only.
FMS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.06 Max: N/A
Current: 0.08
Equity-to-Asset 0.40
FMS's Equity-to-Asset is ranked lower than
62% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. FMS: 0.40 )
Ranked among companies with meaningful Equity-to-Asset only.
FMS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34  Med: 0.4 Max: 0.5
Current: 0.4
0.34
0.5
Interest Coverage 5.98
FMS's Interest Coverage is ranked lower than
58% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 8.41 vs. FMS: 5.98 )
Ranked among companies with meaningful Interest Coverage only.
FMS' s Interest Coverage Range Over the Past 10 Years
Min: 3.95  Med: 4.88 Max: 6.3
Current: 5.98
3.95
6.3
Piotroski F-Score: 7
Altman Z-Score: 2.50
Beneish M-Score: -2.51
WACC vs ROIC
4.20%
10.43%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating Margin % 15.02
FMS's Operating Margin % is ranked higher than
74% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.39 vs. FMS: 15.02 )
Ranked among companies with meaningful Operating Margin % only.
FMS' s Operating Margin % Range Over the Past 10 Years
Min: 13.9  Med: 15.69 Max: 16.51
Current: 15.02
13.9
16.51
Net Margin % 7.22
FMS's Net Margin % is ranked higher than
63% of the 268 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. FMS: 7.22 )
Ranked among companies with meaningful Net Margin % only.
FMS' s Net Margin % Range Over the Past 10 Years
Min: 6.15  Med: 7.65 Max: 8.6
Current: 7.22
6.15
8.6
ROE % 13.36
FMS's ROE % is ranked higher than
66% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 9.35 vs. FMS: 13.36 )
Ranked among companies with meaningful ROE % only.
FMS' s ROE % Range Over the Past 10 Years
Min: 11.2  Med: 13.5 Max: 14.49
Current: 13.36
11.2
14.49
ROA % 5.26
FMS's ROA % is ranked higher than
61% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 3.85 vs. FMS: 5.26 )
Ranked among companies with meaningful ROA % only.
FMS' s ROA % Range Over the Past 10 Years
Min: 4.27  Med: 5.32 Max: 6.16
Current: 5.26
4.27
6.16
ROC (Joel Greenblatt) % 45.08
FMS's ROC (Joel Greenblatt) % is ranked higher than
76% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 16.38 vs. FMS: 45.08 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
FMS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 39.14  Med: 43.67 Max: 50.54
Current: 45.08
39.14
50.54
3-Year Revenue Growth Rate 16.50
FMS's 3-Year Revenue Growth Rate is ranked higher than
80% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. FMS: 16.50 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
FMS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -18.1  Med: 8.9 Max: 22.3
Current: 16.5
-18.1
22.3
3-Year EBITDA Growth Rate 14.90
FMS's 3-Year EBITDA Growth Rate is ranked higher than
70% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. FMS: 14.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
FMS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 8.6 Max: 57.7
Current: 14.9
0
57.7
3-Year EPS without NRI Growth Rate 13.30
FMS's 3-Year EPS without NRI Growth Rate is ranked higher than
60% of the 144 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. FMS: 13.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
FMS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -23.4  Med: 12.6 Max: 61.8
Current: 13.3
-23.4
61.8
GuruFocus has detected 3 Warning Signs with Fresenius Medical Care AG & Co. KGaA $FMS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» FMS's 30-Y Financials

Financials (Next Earnings Date: 2017-08-03 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Fresenius Medical Care AG & Co. KGaA

SymbolPriceYieldDescription
FME3.Germany54.200.96

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621492    SIC: 8092
Compare:NYSE:HCA, NYSE:DVA, OTCPK:IHHHF, OTCPK:FSNUY, NYSE:UHS, OTCPK:SKHCF, NAS:WOOF, NYSE:EVHC, OTCPK:NMHLY, OTCPK:CAKFY, NYSE:MD, NYSE:HLS, NAS:ACHC, NYSE:CHE, NAS:LPNT, OTCPK:LTGHY, NAS:AMED, NYSE:SEM, NYSE:THC, NYSE:AMN » details
Traded in other countries:FME.Austria, FMEN.Germany, FME.Italy, FMEN.Mexico, FME.Switzerland, 0H9X.UK, FMCQF.USA,
Headquarter Location:Germany
Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company, which is operating in both the field of dialysis products and dialysis services.

Based in Germany, Fresenius Medical Care is the largest global dialysis provider, with over 300,000 patients in North America, Europe, Latin America, and Asia. Fresenius operates over 2,270 clinics in North America, 700 in Europe, 360 in Asia-Pacific, and 230 in Latin America. Fresenius also sells dialysis machines and disposables, which represent nearly 20% of the company's revenue.

Ratios

vs
industry
vs
history
PE Ratio 20.85
FMS's PE Ratio is ranked higher than
65% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 26.08 vs. FMS: 20.85 )
Ranked among companies with meaningful PE Ratio only.
FMS' s PE Ratio Range Over the Past 10 Years
Min: 13.27  Med: 20.16 Max: 28.39
Current: 20.85
13.27
28.39
Forward PE Ratio 22.12
FMS's Forward PE Ratio is ranked lower than
56% of the 63 Companies
in the Global Medical Care industry.

( Industry Median: 21.14 vs. FMS: 22.12 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 20.90
FMS's PE Ratio without NRI is ranked higher than
68% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. FMS: 20.90 )
Ranked among companies with meaningful PE Ratio without NRI only.
FMS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.23  Med: 20.18 Max: 28.36
Current: 20.9
13.23
28.36
Price-to-Owner-Earnings 21.17
FMS's Price-to-Owner-Earnings is ranked higher than
67% of the 107 Companies
in the Global Medical Care industry.

( Industry Median: 27.27 vs. FMS: 21.17 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
FMS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.82  Med: 20.74 Max: 34.53
Current: 21.17
12.82
34.53
PB Ratio 2.64
FMS's PB Ratio is ranked lower than
52% of the 249 Companies
in the Global Medical Care industry.

( Industry Median: 2.47 vs. FMS: 2.64 )
Ranked among companies with meaningful PB Ratio only.
FMS' s PB Ratio Range Over the Past 10 Years
Min: 1.67  Med: 2.52 Max: 3.03
Current: 2.64
1.67
3.03
PS Ratio 1.51
FMS's PS Ratio is ranked higher than
58% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 1.71 vs. FMS: 1.51 )
Ranked among companies with meaningful PS Ratio only.
FMS' s PS Ratio Range Over the Past 10 Years
Min: 1.03  Med: 1.51 Max: 1.84
Current: 1.51
1.03
1.84
Price-to-Free-Cash-Flow 24.62
FMS's Price-to-Free-Cash-Flow is ranked higher than
50% of the 117 Companies
in the Global Medical Care industry.

( Industry Median: 24.29 vs. FMS: 24.62 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
FMS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 14.47  Med: 23.91 Max: 54.08
Current: 24.62
14.47
54.08
Price-to-Operating-Cash-Flow 13.20
FMS's Price-to-Operating-Cash-Flow is ranked higher than
59% of the 169 Companies
in the Global Medical Care industry.

( Industry Median: 15.22 vs. FMS: 13.20 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
FMS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.69  Med: 12.48 Max: 19.61
Current: 13.2
9.69
19.61
EV-to-EBIT 12.98
FMS's EV-to-EBIT is ranked higher than
79% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 20.08 vs. FMS: 12.98 )
Ranked among companies with meaningful EV-to-EBIT only.
FMS' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.3  Med: 12.7 Max: 16.2
Current: 12.98
7.3
16.2
EV-to-EBITDA 10.16
FMS's EV-to-EBITDA is ranked higher than
74% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.13 vs. FMS: 10.16 )
Ranked among companies with meaningful EV-to-EBITDA only.
FMS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.9  Med: 10.1 Max: 12.5
Current: 10.16
5.9
12.5
PEG Ratio 2.23
FMS's PEG Ratio is ranked higher than
66% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 3.08 vs. FMS: 2.23 )
Ranked among companies with meaningful PEG Ratio only.
FMS' s PEG Ratio Range Over the Past 10 Years
Min: 1.01  Med: 2.16 Max: 21.65
Current: 2.23
1.01
21.65
Shiller PE Ratio 30.33
FMS's Shiller PE Ratio is ranked lower than
53% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 28.83 vs. FMS: 30.33 )
Ranked among companies with meaningful Shiller PE Ratio only.
FMS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.85  Med: 28.69 Max: 46.19
Current: 30.33
20.85
46.19
Current Ratio 1.32
FMS's Current Ratio is ranked higher than
50% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. FMS: 1.32 )
Ranked among companies with meaningful Current Ratio only.
FMS' s Current Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.41 Max: 1.93
Current: 1.32
0.8
1.93
Quick Ratio 1.07
FMS's Quick Ratio is ranked lower than
58% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. FMS: 1.07 )
Ranked among companies with meaningful Quick Ratio only.
FMS' s Quick Ratio Range Over the Past 10 Years
Min: 0.7  Med: 1.15 Max: 1.61
Current: 1.07
0.7
1.61
Days Inventory 39.32
FMS's Days Inventory is ranked lower than
75% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 15.65 vs. FMS: 39.32 )
Ranked among companies with meaningful Days Inventory only.
FMS' s Days Inventory Range Over the Past 10 Years
Min: 34.35  Med: 37.79 Max: 40.71
Current: 39.32
34.35
40.71
Days Sales Outstanding 73.37
FMS's Days Sales Outstanding is ranked lower than
84% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.13 vs. FMS: 73.37 )
Ranked among companies with meaningful Days Sales Outstanding only.
FMS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 71.64  Med: 76 Max: 83.04
Current: 73.37
71.64
83.04
Days Payable 15.25
FMS's Days Payable is ranked lower than
82% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 45.04 vs. FMS: 15.25 )
Ranked among companies with meaningful Days Payable only.
FMS' s Days Payable Range Over the Past 10 Years
Min: 15.25  Med: 19.24 Max: 28.3
Current: 15.25
15.25
28.3

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.05
FMS's Dividend Yield % is ranked lower than
68% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. FMS: 1.05 )
Ranked among companies with meaningful Dividend Yield % only.
FMS' s Dividend Yield % Range Over the Past 10 Years
Min: 0.91  Med: 1.32 Max: 2.07
Current: 1.05
0.91
2.07
Dividend Payout Ratio 0.20
FMS's Dividend Payout Ratio is ranked higher than
81% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 0.39 vs. FMS: 0.20 )
Ranked among companies with meaningful Dividend Payout Ratio only.
FMS' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.2  Med: 0.25 Max: 0.28
Current: 0.2
0.2
0.28
3-Year Dividend Growth Rate 2.20
FMS's 3-Year Dividend Growth Rate is ranked lower than
76% of the 83 Companies
in the Global Medical Care industry.

( Industry Median: 11.60 vs. FMS: 2.20 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
FMS' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 7.1
Current: 2.2
0
7.1
Forward Dividend Yield % 1.05
FMS's Forward Dividend Yield % is ranked lower than
70% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.91 vs. FMS: 1.05 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.29
FMS's 5-Year Yield-on-Cost % is ranked lower than
66% of the 316 Companies
in the Global Medical Care industry.

( Industry Median: 2.40 vs. FMS: 1.29 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
FMS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.12  Med: 1.62 Max: 2.54
Current: 1.29
1.12
2.54
3-Year Average Share Buyback Ratio -0.50
FMS's 3-Year Average Share Buyback Ratio is ranked higher than
73% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. FMS: -0.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
FMS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -11.8  Med: -0.5 Max: 8
Current: -0.5
-11.8
8

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.26
FMS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
73% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 1.95 vs. FMS: 1.26 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
FMS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.95  Med: 1.36 Max: 2.02
Current: 1.26
0.95
2.02
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.52
FMS's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
63% of the 35 Companies
in the Global Medical Care industry.

( Industry Median: 1.63 vs. FMS: 1.52 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.00
FMS's Price-to-Median-PS-Value is ranked higher than
60% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. FMS: 1.00 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
FMS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.18  Med: 0.98 Max: 1.69
Current: 1
0.18
1.69
Price-to-Peter-Lynch-Fair-Value 2.18
FMS's Price-to-Peter-Lynch-Fair-Value is ranked lower than
51% of the 57 Companies
in the Global Medical Care industry.

( Industry Median: 2.10 vs. FMS: 2.18 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
FMS' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.94  Med: 2.11 Max: 4.25
Current: 2.18
0.94
4.25
Earnings Yield (Greenblatt) % 7.71
FMS's Earnings Yield (Greenblatt) % is ranked higher than
83% of the 270 Companies
in the Global Medical Care industry.

( Industry Median: 3.82 vs. FMS: 7.71 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
FMS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 6.2  Med: 7.9 Max: 13.7
Current: 7.71
6.2
13.7
Forward Rate of Return (Yacktman) % 12.89
FMS's Forward Rate of Return (Yacktman) % is ranked higher than
59% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 10.40 vs. FMS: 12.89 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
FMS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -4.7  Med: 12.7 Max: 18.4
Current: 12.89
-4.7
18.4

More Statistics

Revenue (TTM) (Mil) $19,367.35
EPS (TTM) $ 2.28
Beta0.84
Short Percentage of Float0.00%
52-Week Range $38.05 - 50.22
Shares Outstanding (Mil)612.61 (ADR)

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 18,789 19,973 20,323
EPS ($) 2.83 3.22 2.45
EPS without NRI ($) 2.83 3.22 2.45
EPS Growth Rate
(Future 3Y To 5Y Estimate)
8.00%
Dividends per Share ($) 0.49 0.51 0.56
» More Articles for FMS

Headlines

Articles On GuruFocus.com
Annaly Capital Management: Attractive 9.5% Dividend Yield, but Interest Rates Are a Major Risk Jun 25 2017 
Never a Better Time to Pile on Chipotle Jun 25 2017 
Boeing Takes Lead Over Airbus With $30 Billion Worth of Orders on Day 1 of Paris Air Show Jun 25 2017 
Berkshire Hathaway’s Recent Investment: Home Capital Group Jun 25 2017 
Stocks That Fell to 3-Year Lows in the Week of June 23 Jun 24 2017 
Weekly Top Insider Buys Highlight for the Week of June 23 Jun 24 2017 
ID Watchdog Announces Special and Annual General Meeting Date and Record Date Jun 23 2017 
Ironclad Performance Wear Postpones 2017 Annual Meeting of Stockholders Jun 23 2017 
Delta and Korean Air Create Leading trans-Pacific Joint Venture Jun 23 2017 
Harwood Feffer LLP Announces Investigation of EnerNOC, Inc. Jun 23 2017 

More From Other Websites
Frenova Renal Research Announces Expansion of F1RST Up™ (Frenova Rapid STart Up) Alliance of... Jun 20 2017
ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : June 9, 2017 Jun 09 2017
ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : May 19, 2017 May 19 2017
Fresenius Medical Care AG & Co. KGaA :FMS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18,... May 18 2017
John Oliver ripped into a CEO who proudly compared his healthcare business to Taco Bell May 15 2017
Fresenius Medical Care AG & Co. KGaA : FMS-US: Dividend Analysis : May 15th, 2017 (record date) : By... May 11 2017
Fresenius Medical Care US Finance, Inc. -- Moody's upgrades Fresenius Medical Care to Baa3; stable... May 11 2017
Keryx (KERX) Q1 Loss Wider than Expected, Revenues Beat May 05 2017
Fresenius beats Street 1Q forecasts May 03 2017
[$$] Revelstoke Capital Adds Operating Partner to Team May 02 2017
How Trump’s First 100 Days Affected the Healthcare Industry May 01 2017
Fresenius Buys Akorn -- What Now? May 01 2017
Fresenius Medical Care North America Announces Kidney Walk National Team in Support of the National... Apr 20 2017
New President of FreseniusRx to Build on Company’s Success in Contributing to Positive Patient... Apr 13 2017
Analyst: Akorn Could Be Sold For As Much As $34 Per Share, But There's Double-Digits Downside If... Apr 11 2017
Fresenius Medical Care AG & Co. KGaA Published Form 20-F for the Fiscal Year 2016 Apr 10 2017
Akorn Launches To Six-Month High On Fresenius Takeover Rumor Apr 07 2017
Akorn shares surge 20% on report Germany's Fresenius is mulling a bid Apr 07 2017
Fresenius (FMS) Acquires 70% Stake in Kunming Wuhua Hospital Apr 07 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}